Explore the detailed record of transactions filed by 강종구, Executive. Insider active across 2 companies, notably 바이오톡스텍. In total, 21 reports have been published. Regulator: DART (FSS). The full history is free.
Declarations 21 total
● Executives · 12 Mar 2026 (filed)
● Executives · 6 Mar 2026 (filed) · 바이오톡스텍 ● Executives · 9 Feb 2026 (filed) · 바이오톡스텍 19,802 shares DART:20260209000105 Ideal exit: 6 Nov 2026 (T+270) ● Executives · 22 Jan 2026 (filed) · 바이오톡스텍 22,581 shares DART:20260122000059 Ideal exit: 19 Oct 2026 (T+270) ● Executives · 15 Jan 2026 (filed) · 바이오톡스텍 7,275 shares DART:20260115000035 Ideal exit: 12 Oct 2026 (T+270) ● Executives · 8 Jan 2026 (filed) · 바이오톡스텍 3,789 shares DART:20260108000112 Ideal exit: 5 Oct 2026 (T+270) ● Executives · 10 Dec 2025 (filed) · 바이오톡스텍 18,678 shares DART:20251210000144 Ideal exit: 6 Sept 2026 (T+270) ● Executives · 30 Dec 2024 (filed) · 바이오톡스텍 4,500 shares DART:20241230000029 Ideal exit: 26 Sept 2025 (T+270) ● Executives · 23 Dec 2024 (filed) · 바이오톡스텍 42,855 shares DART:20241223000323 Ideal exit: 19 Sept 2025 (T+270) ● Executives · 10 Dec 2024 (filed) · 바이오톡스텍 13,523 shares DART:20241210000080 Ideal exit: 6 Sept 2025 (T+270) ● Executives · 9 Dec 2024 (filed) · 바이오톡스텍 9,800 shares DART:20241209000030 Ideal exit: 5 Sept 2025 (T+270) ● Executives · 6 Dec 2024 (filed) · 바이오톡스텍 17,524 shares DART:20241206000056 Ideal exit: 2 Sept 2025 (T+270) ● Executives · 5 Dec 2024 (filed) · 바이오톡스텍 12,034 shares DART:20241205000082 Ideal exit: 1 Sept 2025 (T+270) ● Executives · 11 Sept 2024 (filed) · 바이오톡스텍 ● Executives · 13 Mar 2024 (filed)
● Executives · 14 Mar 2023 (filed)
● Executives · 14 Mar 2023 (filed)
● Executives · 28 Mar 2022 (filed)
● Executives · 10 Mar 2022 (filed)
● Executives · 8 Mar 2022 (filed)
● Executives · 10 Mar 2021 (filed)
About 강종구 강종구 is an executive at the company 바이오톡스텍. He is involved in the management and strategic development of the company, which specializes in the biopharmaceutical sector. 강종구 plays an important role in the direction and growth of 바이오톡스텍.